Dynavax Technologies | search
Click here to view Dynavax Technologies news from 60+ newspapers.
Bookmark or Share- Pipeline | CpG 1018 | Dynavax TechnologiesDynavax’s pipeline is focused on harnessing our CpG 1018 adjuvant as an advanced vaccine adjuvant to discover, develop, and commercialize promising vaccines to prevent infections diseases.
- Careers at Dynavax TechnologiesDynavax is dedicated to developing and commercializing innovative vaccines to help protect the world against infectious diseases. We are a dynamic team with diverse backgrounds, and we like it that way.
- Dynavax Technologies | Toll-like Receptor | VaccinesDynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
- Our Science | Toll-like Receptor biology - DynavaxAt Dynavax Technologies, we are developing cutting-edge vaccines based on Toll-like Receptor (TLR) biology and its ability to control and modulate the immune system.
- About | Core Values | Management | Board of Director | Dynavax TechnologiesDynavax GmbH (Dynavax Europe), is the European affiliate of Dynavax Technologies Corporation. For more than 25 years, we have been dedicated to the development and manufacturing of vaccines and biopharmaceuticals.
More
